Blog
Insights on data analysis, AI, and the platform we're building at Portrai.
Latest
29 articles
Comparative analysis and integration of image-based and high-resolution sequence-based spatial transcriptomics platforms for tumor microenvironment analysis
Advances in spatial transcriptomics (ST) enable precise gene expression analysis within the tumor microenvironment (TME). VisiumHD and Xenium Prime 5K are cutting-edge platforms offering unique str...

Target-based Understanding the Termination of the AMG 794 Clinical Trial: A Deep Dive with spatial transcriptomics data
Amgen has exited the competitive development of Claudin 6 (CLDN6) therapies, which is still in its early stages, based on initial data from preclinical studies. Amgen, on July 5th 2024, had terminated
WRITTEN BY
Portrai's Authors
Capturing and compounding Portrai's insights.
Daeseung Lee
CEO
Physician-scientist who left clinical practice to bring spatial biology into oncology drug discovery
Hongyoon Choi
CTO
Builds the algorithms that turn spatial transcriptomics into actionable target intelligence
Hyung-Jun Im
CSO
Nuclear medicine specialist linking imaging biomarkers to next-generation radiopharmaceuticals
Kwonjoong Na
CMO
Translates platform insights into IND-enabling decisions across oncology programs
Portrai
Official posts from the Portrai team, decoding disease with spatial intelligence